Clinical Pharmacy Definition

Clinical Pharmacy is the branch of pharmacy where pharmacists provide patient care that optimizes medication use and promotes health, wellness, and disease prevention. It is a patient-oriented practice that began in hospitals and clinics.

1. The Clinical Pharmacist

A clinical pharmacist is an expert in the therapeutic use of medications, responsible for evaluating and recommending drugs to patients and healthcare professionals.

Core Functions:

  • Prescribing drugs (in collaborative practice settings)
  • Dispensing and administering drugs
  • Documenting professional services
  • Direct patient involvement and counseling
  • Reviewing drug use for appropriateness
  • Educating patients and healthcare staff
  • Consultation on therapeutic regimens

2. Aim & Scope of Clinical Pharmacy

Aim:

To ensure the patient's maximum wellbeing and to play a meaningful role in the safe and rational use of drugs.

Main Roles:

  1. Assist physicians in prescribing and monitoring drug therapy.
  2. Assist medical/paramedical staff in documenting medication indications.
  3. Maximize patient compliance in the drug use process.

Scope:

  • Drug Information
  • Drug Utilization Review
  • Drug Distribution Systems
  • Drug Selection & Evaluation
  • Pharmacy Education & Teaching

3. Qualities & Role in Healthcare Team

Essential Qualities:

  • Good Communication Skills
  • Clinical Skills & Knowledge
  • Professional Relationship Building
  • Empathy
  • Ability to Monitor Drug Therapy

Roles in Healthcare Team:

  • Taking medication history
  • Identifying and managing drug interactions
  • Selection of appropriate drug therapy
  • Drug therapy monitoring
  • Adverse drug reaction management
  • Drug policy development
  • Research and drug information provision

4. Clinical Pharmacokinetics (PK)

Clinical Pharmacokinetics is the science of the rate of drug movement within biological systems, as affected by Absorption, Distribution, Metabolism, and Elimination (ADME).

PK vs. PD:

  • Pharmacokinetics (PK): "What the body does to the drug" - ADME processes.
  • Pharmacodynamics (PD): "What the drug does to the body" - Drug effects at the site of action.

Kinetic Processes:

Zero-Order Kinetics

Plasma drug concentration decreases at a constant rate (linear).

Examples: IV infusion, depot injections (e.g., Fluphenazine decanoate).

First-Order Kinetics

Rate of elimination is proportional to drug concentration (exponential).

Most drugs follow this pattern.

5. ADME Processes

Absorption:

Factors affecting: Molecular weight, ionization, solubility, formulation, route, gastric pH, GI contents.

Pediatric Considerations: GI pH changes, gastric emptying, enzymes, bile acids, flora.

Distribution:

Influenced by: Membrane permeability, plasma protein binding, lipophilicity, Volume of Distribution (Vd).

Pediatric Differences: ↑ total body water, ↓ adipose tissue, altered protein binding.

Metabolism:

Primarily hepatic. Converts drugs to more water-soluble forms for elimination.

  • Phase I: Cytochrome P450 system (oxidation, reduction, hydrolysis)
  • Phase II: Conjugation (glucuronidation, sulfation, glycine conjugation)

Elimination:

Routes: Renal (primary), biliary/feces, pulmonary.

Pediatric Elimination: Renal function matures by ~3 years; neonates have prolonged elimination.

6. Basic PK Parameters

Parameter Symbol Definition & Utility
Volume of Distribution Vd Apparent volume occupied by drug. Determines loading dose and distribution characteristics.
Clearance Cl Efficiency of drug removal from body. Determines maintenance dose and steady-state concentration.
Half-Life t1/2 Time for drug concentration to reduce by 50%. Guides dosing interval and time to steady-state.

Key Relationships:

t1/2 = (0.693 × Vd) / Cl

Steady-State (Css): Achieved after 4-5 half-lives. Amount administered = amount eliminated.

Loading Dose: Used when immediate therapeutic effect is needed (e.g., digoxin, lidocaine).

Elimination Patterns:

  • First-Order (Linear): Rate ∝ concentration (most drugs)
  • Michaelis-Menten (Non-linear): Saturation kinetics (e.g., phenytoin)

7. Clinical PK Study Methodology

1. Administration Scheme:

  • Single and multiple dose studies within therapeutic range.
  • Continue multiple dosing until steady-state is achieved.
  • Investigate accumulation and non-linearity.

2. Subject Selection:

  • Initial: Healthy volunteers (fasting, controlled conditions).
  • Further: Target patient population.
  • Special populations: pediatric, geriatric, hepatic/renal impairment.
  • Consider food effects, genetics, comorbidities, concomitant medications.

3. Sampling & Analysis:

  • Adequate blood samples to characterize absorption, distribution, elimination phases.
  • Sample beyond 2-3 half-lives to distinguish distribution/elimination.
  • Urine collection until no detectable drug/metabolites.
  • Analytical methods: HPLC, spectrophotometry - must be specific, accurate, precise.
  • Mathematical modeling and statistical analysis of PK parameters.